A retrospective analysis suggests that recent NOAC use is not associated with increased risk for symptomatic intracranial hemorrhage after treatment with IV alteplase for acute ischemic stroke.
This retrospective cohort study uses data from hospitals participating in the Get With The Guidelines–Stroke registry on patients with acute ischemic stroke and